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Transcription factors are commonly involved in leukemia by activation through chromosomal translocations and normally
function in cell type(s) that differ from that of the tumor. TAL2 is a member of a basic helix–loop–helix gene family
specifically involved in T cell leukemogenesis. Null mutations of Tal2 have been made in mice to determine its function
during development. Tal2 null mutant mice show no obvious defects of hematopoiesis. During embryogenesis, Tal2
expression is restricted to the developing midbrain, dorsal diencephalon, and rostroventral diencephalic/telencephalic
boundary, partly along presumptive developing fiber tracts. The null mutant mice are viable at birth but growth become
progressively retarded and they do not survive to reproductive age. Tal2-deficient mice show a distinct dysgenesis of the
midbrain tectum. Due to loss of superficial gray and optical layers, the superior colliculus is reduced in size and the inferior
colliculus is abnormally rounded and protruding. Death is most likely due to progressive hydrocephalus which appears to
be caused by obstruction of the foramen of Monro (the connection between the ventricles of the forebrain). Thus, in addition
to its oncogenicity when ectopically expressed, Tal2 normally plays a pivotal role in brain development and without this
ene, mice cannot survive to maturity.
Key Words: homologous recombination; chromosomal translocations; leukemia; transcription; helix–loop–helix; tectum;
rain; hydrocephalus; cancer.b
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tINTRODUCTION
Chromosomal translocations have not only yielded a
plethora of new oncogenes which have tissue-specific tro-
pism in tumorigenesis but also have been a source of
important new transcription factors which are often asso-
ciated with specific developmental processes in their nor-
mal sites of expression (Rabbitts, 1994). Various members
of the basic helix–loop–helix (bHLH) gene family have been
found at the junctions of chromosomal translocations. This
family of proteins plays a role in normal development by
1 Present address: Virco UK Ltd., Unit 184, Cambridge Science
Park, Milton Road, Cambridge CB4 0GA, UK.
2 Present address: Centre for Genome Research, University of
dinburgh, West Mains Road, Edinburgh EH9 3JQ, UK.
3 Present address: Department of Pathology, Columbia Univer-
sity, New York, NY 10032.
0012-1606/00 $35.00oth protein–protein interaction and by protein–DNA in-
eractions, for example, in hematopoiesis and vasculogen-
sis (Tal1, also called Scl), myogenesis (myoD, myogenin),
evelopment of the neuroendocrine system (sim1), and
etina (Nabeshima et al., 1993; Robb et al., 1995, 1996;
orcher et al., 1996; Michaud et al., 1998; Cepko, 1999).
he TAL family of bHLH genes has three known members
LYL1, TAL1, and TAL2), each of which is activated by
hromosomal translocations associated with T cell acute
ymphoblastic leukemia (Baer, 1993). Indeed, TAL1 is ma-
ignantly activated in most cases of pediatric T-ALL, even
n the absence of a chromosomal translocation (Bash et al.,
995). Given the striking sequence homology between their
espective bHLH domains, it is likely that TAL1, TAL2, and
YL1 promote tumorigenesis by a common mechanism. All
hree proteins dimerize with members of the class A
ubgroup of bHLH protein (i.e., E47, E12, E2-2, and HEB)
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534 Bucher et al.(Hsu et al., 1991, 1994; Xia et al., 1994; Miyamoto et al.,
1996), as well as the leukemogenic LIM-only proteins,
LMO1 and LMO2 (Valge-Archer et al., 1994; Wadman et al.,
1994, 1997). Tal1–Lmo2 interactions appear to play a role in
tumorigenesis as tumor occurrence in transgenic mice
coexpressing Tal1 and Lmo2 have an increased tumor
incidence (Larson et al., 1996).
The TAL2 gene is activated in the chromosomal translo-
cation t(7;9) (q35;q34) in a subset of T-ALL patients (Reyn-
olds et al., 1987; Westbrook et al., 1987; Tycko et al., 1989;
Xia et al., 1991), causing enforced TAL2 expression in the T
cell lineage. Previously normal Tal2 expression had been
described in adult testes (Xia et al., 1991) and using in situ
hybridization revealed expression of the gene in the devel-
oping midbrain, diencephalon, and anterior pons (Mori et
al., 1999). These studies raise questions about Tal2 function
in brain development. In addition, as TAL2-associated chro-
mosomal translocations have only been found in T cell
tumors, it seemed possible that TAL2 might also have a role
in normal hematopoiesis. Therefore, null mutation of the
mouse Tal2 gene was made by homologous recombination
to investigate the role of Tal2 in mouse development. Mice
homozygous for this mutation have no obvious defect of
hematopoiesis. Instead we observed early postnatal lethal-
ity coinciding with a progressive hydrocephalus that devel-
oped due to obstruction of the foramen of Monro. In
addition dysgenesis of the midbrain tectum occurred. Thus
Tal2 plays a pivotal role in development of the mature
central nervous system.
MATERIALS AND METHODS
Construction of the Targeting Vector
Genomic DNA clones of mouse Tal2 were isolated by screening
a l2001 library of strain 129-derived E14 TG2a ES cell DNA
(Warren et al., 1994) by hybridization with T3.1B2S, a genomic
NA fragment that contains coding sequences of human TAL2
Xia et al., 1991). A 10.2-kb HindII–EcoRI fragment of Tal2 DNA
(see Fig. 1) was subcloned into the pBluescript-KS plasmid vector
(Stratagene). A 0.8-kb BglII–SmaI fragment containing coding se-
quences for the C-terminal 103 residues of the 108 amino acid Tal2
polypeptide was removed and replaced with a 5.0-kb fragment
containing the lacZ and MC1-neo cassettes (Thomas and Capecchi,
1987). The final targeting construct was generated by placing a
1.8-kb MC1-tk cassette adjacent to the 39-end of the subcloned Tal2
genomic DNA.
Gene Targeting and Genomic Analysis
The targeting construct was linearized at a unique SalI site prior
to electroporation of the E14 or CCB line of ES cells. ES cells in
which homologous recombination had occurred were selected in
G418 and gancyclovir (Thomas and Capecchi, 1987) and DNA was
analyzed by filter hybridization as described (LeFranc et al., 1986)
sing 59 (pBWBH) and 39 (pTal2HH) external probes (Fig. 1). A single
nsertion by homologous recombination was confirmed with a
eomycin probe. Two independent targeted clones (designated
al2/1 from E14 and Tal2/64 from CCB ES cells) were studied. Chese were injected into C57Bl6 blastocysts and the male chimeric
ice obtained were crossed with C57Bl6 females to produce
ermline carriers of the mutations. These heterozygous mice were
ormal. Crossing heterozygous animals produced homozygous
ffspring for analysis. For genotype analysis, genomic DNA was
creened by PCR using a primer pair specific to the targeted allele
n parallel with a wild-type allele-specific primer pair. Conditions
f PCR were 35 cycles of a touchdown PCR program (Don et al.,
991) (annealing temperature decreasing from 65 to 55°C): (a)
argeted allele specific, PCR product size 240 bp, PAF1 59 TCG
CT TCT ATC GCC TTC and Tal2B2 59 CAT AAT CCT CAC
GC TCT GCT CCA; and (b) wild-type allele specific, PCR
roduct size 300 bp, Tal2F AAG CTT TAG TCA AAA TGA ATT
CC and Tal2B GAT ATA CCT CAT TGC CAA GCG AAG.
Histology and Determination of Tal2 Expression
X-gal staining during development was carried out essentially as
described (Allen et al., 1988) to reveal lacz expression. Embryos
(E9.5–12.5) were immersion fixed in fresh 4% paraformaldehyde
(PFA)–phosphate-buffered saline (PBS). Duration of fixation was
depending on size (E9.5/30min, E12.5/45min). For embryonal
stages older than E12.5, 0.3% NP-40 was added to the fixation and
washing solutions. Whole-mount immersion staining was per-
formed, after washing in PBS, in the staining solution (0.2% X-gal,
2 mM MgCl2, 5 mM 3H2O, 5 mMK3Fe(CN)6). For stage E16.5, the
brain was dissected from the surrounding tissue and fixed for 1 h,
equilibrated in 30% sucrose–PBS. Sixty-micrometer cryosections
were cut on a sliding microtome and X-gal stained thereafter.
Sections were postfixed after staining in 4% PFA and counter-
stained with neutral red. Postnatal animals younger than 10 days
were killed with an intraperitoneal lethal injection of Euthanol,
and brains were dissected and immersion fixed overnight in 4%
PFA. Older animals were killed with an intraperitoneal lethal
injection, gravity perfused (Dh 70 cm) with 4% PFA, and postfixed
for 4 h. All brains were equilibrated in 30% sucrose before
sectioning on a freezing stage microtome at 40 mm. Separate series
f sections (1:6) were mounted on glass slides and stained with
resyl violet or stained for acetylcholinesterase activity by the
hiocholine reaction, using 0.01% ethoproprazine to inhibit non-
pecific esterases and 0.25% silver nitrate to enhance the sulfide
eaction product.
Flow Cytometric Analysis of Cell Surface Marker
Expression
Single-cell suspensions were prepared from mouse thymus,
spleen, and bone marrow. One-hundred microliters of cells (5 3
07/ml) was incubated at 4°C for 20 min in PBS with 5% fetal calf
erum (FCS) with the following antibodies: CD4, CD8, CD25,
D44, Ter119, B22O, and Thy1. Antibodies (PharMingen) were
onjugated with either fluorescein isothiocyanate (FITC) or phyco-
rythrin (PE). Isotype-matched fluoresceinated antibodies were
sed as controls for nonspecific immunofluorescence. After anti-
ody labeling, cells were washed once with PBS containing 5% FCS
nd resuspended in 1 ml of PBS/5% FCS. Flow cytometric analysis
as performed using a FACScalibur (Becton Dickinson, San Jose,
A) and analyzed with Cell Quest software (Becton Dickinson).
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535Abnormal Brain Development in Tal2 Null MiceRESULTS
Null Mutation of Tal2 Results in Postnatal
Lethality
The 108 codons that specify the full-length Tal2 protein
FIG. 1. Gene targeting to fuse the lacZ gene into the exon of Tal
xon. The location of the 59 probe (pBWBH) and 39 probe (pTal2H
enoted by the box; within this exon, the Tal2 coding sequences (32
;3.6 kb) by a shaded box. (B) The replacement vector used for target
the insertion of a cassette carrying the lacZ and MC1-neo genes (t
(Thomas and Capecchi, 1987) was added at the 39 end of the vec
replacement vector, the hatched box indicates the position of th
pBluescript vector (pBS). Horizontal arrows indicate the direction
predicted structure of the targeted Tal2 allele following homologous
lengths of the recombined XbaI (17.5 kb) and SacI (10 kb) restri
Enzymes: B, BamHI; H3, HindIII; R, EcoRI; B2, BglII; Sm, SmaI, S,
litter of a Tal2 heterozygous cross compared with nontargeted ES
.8% agarose, and transferred to nylon membrane followed by hybri
robe as shown. The bands corresponding to targeted alleles are pr
as a single band that hybridizes with the neomycin probe, corresp
oelectrophoresis of l phage DNA cleaved with HindIII.are contained within a single exon of the mouse Tal2 geneFig. 1A). A null allele of Tal2 was made in ES cells using a
argeting vector in which the sequences for the codons
–108 were replaced with the bacterial b-galactosidase
(lacZ) gene (Fig 1B). In addition, the MC1-neo cassette
(Thomas and Capecchi, 1987) was introduced as a selectable
) Structure of the wild-type Tal2 gene around its the single coding
indicated above the restriction map of Tal2. The coding exon is
are represented by a closed box, and the 39-untranslated sequences
al2. A deletion was introduced into the Tal2 exon coincident with
tter providing selection for targeted clones). The MC1-tk cassette
or negative selection of nonhomologous integration. Within the
C1-tk cassette and the dashed line represents sequences of the
anscription of the lacZ, MC1-neo, and MC1-tk cassettes. (C) The
mbination. Only relevant restriction sites are shown. The expected
fragments diagnostic of homologous recombination are shown.
; Sl, SalI, Xb, XbaI. (D) Filter hybridization of genomic DNA from
DNA (CCB). DNA was digested with XbaI or SacI, fractionated on
ion with the 59 (pBWBH) or 39 (Tal2HH) Tal2 probes or a neomycin
t in mice 1, 2, and 4 (heterozygous mice); each of these mice also
ng to the homologous recombination site. Sizes were estimated by2. (A
H) is
4 bp)
ing T
he la
tor f
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ondimarker. Homologous recombination was carried out in two
536 Bucher et al.ES lines (E14 and CCB), which gave similar results when
mice were generated after injection of the targeted ES cells
into blastocysts and germline transmission was obtained.
The presence of a targeted allele in the germline of mice
was initially determined by filter hybridization using
probes flanking both sides of the targeting segment and
with the neomycin gene to confirm the presence of a single
event (Figs. 1C and 1D).
Once germline transmission was obtained, heterozygous
carriers were interbred to produce homozygous offspring. In
excess of 200 mice were analyzed at the time of weaning
but no homozygous mice were found. However, homozy-
gous pups were found in newborn litters, indicating that the
Tal2 mutation causes lethality between birth and adult
stages. At birth, Tal2 null mutant mice were macroscopi-
cally indistinguishable from their heterozygous and wild-
type littermates. After 10–12 days, however, growth retar-
dation became obvious (Fig. 2B), with weight loss beginning
as early as day 6. The animals showed no signs of illness and
remained active and their feeding and drinking behavior
appeared normal, although there were occasional periods of
decreased activity and convulsions have been observed.
Forty percent of the null mutant mice died between 21 and
24 days after birth and all had died by 32 days (Fig. 2).
Heterozygous mice in were in all respects asymptomatic
and indistinguishable from wild-type mice. Postmortem
examination of thymus, heart, lung, spleen, liver, kidneys,
periadrenal gland, pancreas, and bone marrow (femur) of the
deceased 2/2 animals showed no detectable abnormalities.
In addition, blood chemistries were analyzed (sodium, cal-
cium, potassium, glucose, urea, creatinine) from Tal2 null
mutant mice (at days 15–17) but no significant differences
were found when compared to their wild-type or heterozy-
gous littermates (data not shown). These findings show that
Tal2 homozygous mutant mice cannot survive to maturity.
Hematopoiesis Seems Unaffected by Homozygous
Tal2 Null Mutation
As Tal2 is a T cell oncogene, it was possible that a defect
of hematopoiesis might account for the premature death of
homozygous mice. We examined the cell populations of
thymus, spleen, and bone marrow from three homozygous
Tal2 mutant mice and one wild-type mouse at 16 days of
age. Cell surface marker expression of T cells (CD4 and
CD8; CD25 and CD44), B cells (B220), myeloid cells (Mac-1
and Gr-1), and progenitors (Ter119, Thy1) was examined.
There was no evidence of any disparity between Tal2
mutant mice and the wild-type expression pattern (data not
shown). Thus, while we cannot completely rule out small
changes in the various hematopoietic populations, the data
are consistent with the view that Tal2 null mutation does
not affect hematopoiesis.
Tal2 Expression in CNS Development
As there was no evidence that hematopoiesis was influ-enced by lack of Tal2 protein, we examined Tal2 expressionFIG. 2. Survival of Tal2 homozygous null pups after birth.
Heterozygous Tal2 mice were mated and litters were analyzed
by tail blotting or PCR for the presence of the targeted allele
after 35 days. Pups that died between birth and 35 days were
genotyped. (A) Graph showing the time of death of null mutant
mice. A total number of 27 litters from heterozygous crossings
were studied and counted daily. The time of death of 50
confirmed Tal2 null mutant mice derived from two different ES
clones (25 clone 1, 25 clone 64) is shown. 40% of the null mutant
mice died between day 21 and day 24 after birth. No null mutant
mice were found to survive for more than 32 days. (B) Photo-
graph showing size difference between Tal2 null mutant mouse
(weighing 5.7 g) and wild-type littermate (weighing 9 g) at day
15. At birth, Tal2 null mutant mice are indistinguishable from
their heterozygous and wild-type littermates. Between day 15
and day 17, however, the average null mutant mouse is 44%
lighter than its average littermate.
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537Abnormal Brain Development in Tal2 Null Micepatterns to determine a site which might be relevant to the
phenotype observed. Tal2 expression has been found in
neural tissue using in situ hybridization (Mori et al., 1999).
ince the targeting event had fused the lacZ gene to the
al2 coding exon, the presence of b-galactosidase could be
used as a reporter for the Tal2 promoter activity. In order to
elucidate the effect of Tal2 null mutation we examined the
xpression of Tal2 in embryonic development in stages
10.5, E11.5, E12.5, E16.5, P0, P5, and P15/17. Each stage
as examined in between two and four litters (2/2, 1/2)
nd one wild type, using embryonic or postnatal pups. The
xpression pattern of lacZ was determined in heterozygous
ice (Figs. 3–5) and compared to expression in Tal2 null
utant mice to detect potential differences. However no
ifferences have been found between the expression pat-
erns between Tal2 1/2 and 2/2 mice. During develop-
ent b-galactosidase activity was restricted to the develop-
ng brain, first being detected at E10.5 (Figs. 3A and 3B)
onfined to the ventrolateral mesencephalon (excluding the
idline) and the ventral diencephalic/telencephalic bound-
ry. b-Galactosidase expression in the ventrolateral mesen-
ephalon intensified by about E11.5 and growth of
b-galactosidase-positive axons could be observed projecting
to the midbrain tectum (Fig. 3C). In addition, two bilateral
foci of strong b-galactosidase staining extended into the
diencephalon. Dorsally, staining extended, parallel to the
midline, into the presumptive posterior commissure and
pretectum, but was not connected by commissural fibers at
this stage. Ventrally, staining extended along the zona
limitans intrathalamica (ZLI) into the ventrolateral dien-
FIG. 3. Tal2 gene expression during embryogenesis as monitore
between heterozygous Tal2 mutant mice. At the times indicated, e
(A, B) b-Galactosidase staining patterns an E10.5 embryo at differin
mesencephalon (me) and faint staining occurs in the ventral dience
diencephalon; t, telencephalon. (C) An angle view of an E11.5
mesencephalon, posterior commissure (pc, diencephalon), and zona
in the cranioventral diencephalon/telencephlon (black arrowhead).cephalon. This general b-galactosidase staining pattern inhe midbrain and diencephalon intensified further and
xpanded somewhat by E12.5 (Figs. 4A and 4C).
There is a striking expression of Tal2 in the developing
ber tracts (Fig. 4C). The wave of commissural fibers, that
ross the midline in the cranial midbrain at E11.5, extends
audally during E12 (Figs. 4C, 4E, and 4F). Dense commis-
ural fiber tracts build up in the pretectum and posterior
ommissure (Figs. 4C and 4F–4H). In addition we observed
taining in axons extending from the ZLI to the dorsal
idline (Fig. 4E). The expression at the diencephalic–
elencephalic boundary remained relatively faint and was
onfined to two streaks in the ganglionic eminence (GE)
oining in the optic recess (OR) (Figs. 4D and 4E). Weak
xpression could be found in the mammillary region (Fig.
H).
b-Galactosidase staining, corresponding to Tal2 expres-
sion, weakens after about E16, although some staining
could still be observed in the equivalent regions to those of
earlier stages (Figs. 4 and 5). There was still intense
b-galactosidase staining in the most caudal part of the
midbrain but no expression in the developing hindbrain
(Fig. 5A). The midbrain tectum and posterior commissure
still showed strong staining (Figs. 5C and 5D) and some
weak staining was seen in the mammillary region. At this
stage the ZLI has differentiated into the extramedullary
lamina (EML), delineating the boundary between dorsal and
ventral thalamus (Figs. 5B–5D). We detected lacZ staining
from the presumptive paraventricular nucleus of the hypo-
thalamus to the lateral surface of the EML, which gives rise
to the retinotectal tract and ventrolateral geniculate body
b-galactosidase histochemistry. Timed matings were established
yos (heterozygous) were dissected and whole-mount X-gal stained.
les. The first detectable Tal2 expression occurs in the ventrolateral
ic/telencephalic boundary (black arrows). my, myelencephalon; d,
bryo. This displays strong X-gal staining in the ventrolateral
ans intra-thalamica (shown by white arrowhead) and faint stainingd by
mbr
g ang
phal
em
limit(Fig. 5B). From birth to P15 we can see decreasing staining
tr
mesenchephalon) to the posterior commissure (pc) of the dien-
538 Bucher et al.in the midbrain tectum. We confirmed weak expression in
the midbrain tectum at day 15 by RT-PCR and Northern
filter hybridization analysis (data not shown).
Abnormal Midbrain Development in Tal22/2 Mice
On the basis of Tal2 expression patterns, we examined
he midbrain tectum of Tal22/2 mice. We could not detect
any morphological changes during embryogenesis by com-
paring null mutant with heterozygous and wild-type mice.
At P2, subtle differences in the midbrain tectum enabled us
to identify the Tal2 knockout mice among their litter-
mates. At P15 the dysgenesis of the midbrain tectum was
obvious in all of the 23 null mutant animals examined (Fig.
6). The superior colliculi were reduced in size and the
inferior colliculi were abnormally rounded and protruding.
Histological sections stained with cresyl violet or for ace-
tylcholinesterase activity revealed that the layering in the
superior colliculus was disrupted (Fig. 6).
In the null mutant mice, the superficial gray was hypo-
blastic and developed only in a rudimentary form. This can
best be seen in the acetylcholinesterase (AchE) staining (Fig.
6). In this staining, the whole superficial gray is highly
reactive due to AchE activity of intrinsic cells (Wallace and
Fredens, 1988). The optical layer is reduced in size and
depth, as well as in lateral extension. The deep gray layer as
well as the intermediate gray and white layers appear
unchanged. The abnormalities in the two outer layers are
likely to account for the macroscopically obvious
dysgenesis/size reduction of the superior colliculus.
Postnatal Development of Hydrocephalus in Tal2
Null Mutant Mice
None of the observed expression patterns or distinct
abnormalities found in brain development gave a clear
cephalon. (B) X-gal staining of wild-type mouse serving as negative
control. Black lines indicate levels of sections D–H. (C) The
midbrain tectum of embryo, seen in A, viewed from above. This
shows staining extends along fiber bundles which can be seen
crossing in the posterior commissure (pc). The posterior staining
extends to the midbrain/hindbrain boundary. (D–G) Sliding mic-
rotome sections (60 mm) of the Tal2 1/2 E12.5 embryo at levels
equivalent to those shown in B. D, E show X-gal staining in the
optic recess (OR), ganglionic eminence (GE), posterior commissure
(pc), and zona limitans intrathalamica (ZLI) at low amplification.
This demonstrates the proximity of Tal2 expression to the devel-
oping foramen of Monro and lateral (LGE) and medial ganglionic
eminence (MGE). (F) Section showing expression in the midbrain
tectum and tectal commissural (TC) fiber tracts (G, high magnifi-
cation.). In addition, staining can be seen in fiber bundles running
along the surface of the mesencephalon from the level of the ZLI to
the dorsal midline. (H) Sections showing Tal2 expression in the
midbrain tectum, tectal commissural (TC) fiber tracts, and mam-FIG. 4. Detailed analysis of Tal2 expression at E12.5 as judged by
whole-mount X-gal. Heterozygous Tal2 mice were mated and
embryos recovered at E12.5. All embryos from a litter were
whole-mount stained with X-gal for b-galactosidase activity. Rep-
esentative examples of 1/2 (A) and 1/1 (B) whole-mount em-
bryos are shown. (C–H) Sections through 1/2 embryos. (A) A
lateral view of a Tal2 1/2 embryo (het) with expression extending
rostrally from the floor of the midbrain along the zona limitans
intrathalamica (white arrow) and from the midbrain tectum (me,millary region (MR).
taken. The staining in the parasagittal sections occurs along the
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539Abnormal Brain Development in Tal2 Null Micepossibility to explain the cause of death of the homozygous
mutant animals. Nonetheless, it seems most likely that a
brain defect was behind the premature lethality. Thus
postmortem examination was carried on brains from per-
fused 16-day-old Tal2 homozygous null mutant mice and
their littermates. This analysis revealed severe distortions
of thalamic structures combined with drastic unilateral or
bilateral enlargement of the lateral ventricles in all six
histologically examined knockout mice (the degree of dis-
tortion varied from mouse to mouse) (Fig. 7). An additional
six null mutant animals were macroscopically examined
(using scalpel sections) and all of them showed a macro-
scopic hydrocephalus. This was consistently observed in
Tal2 2/2 mice but not in wild-type or heterozygous Tal2
mice. Hydrocephalus was present only in the lateral ven-
tricles, whereas the third and fourth ventricles were never
distended. The most likely explanation for such findings is
obstruction at the level of the interventricular channel
connecting the lateral and the third ventricles, known as
the foramen of Monro. Consistent with this possibility,
analysis of tissue sections showed uni- or bilateral compres-
sion of the fimbria fornix along the roof of the thalamus
with complete obstruction of the foramen of Monro in all
cases of hydrocephalus examined (Fig. 7). Different postna-
tal stages (P2/3, P5, P8, P12—three null mutant mice and
one wild-type mouse per stage) were histologically analyzed
in order to detect time of onset of the hydrocephalus.
Generally severity of these changes increased with age. The
youngest animal in which we could clearly identify a
hydrocephalus was 5 days old. The time of onset of the
malformations is subject to some variation between indi-
vidual mice. The most likely cause of death is therefore the
hydrocephalus.
DISCUSSION
TAL2 encodes a bHLH transcription factor discovered
because of its capability to contribute to T cell acute
leukemia tumorigenesis when the gene is activated via a
presumptive extramedullary lamina (equivalent to ZLI in earlier
stages), mammillary region (weak), and midbrain tectum. Note the
difference in b-galactosidase expression between the caudal mid-
rain and the developing cerebellum. The coronal section in B
hows X-gal staining in the presumptive extramedullary lamina
EML) delineating the border between dorsal and ventral thalamus.
his structure may serve as path for tract formation such as
ammillothalamic tract and retinotectal tract. The lateral part
ives rise to the ventral lateral geniculate body. In addition,
taining was found in the region of the fasciculus retroflexus (FR).
B–D) Coronal sections at the level of the posterior commissure
PC) and lateral habenula fibers. The expression in the EML extends
rom the lateral part surface of the thalamus to the paraventricularFIG. 5. Tal2 expression in brain at embryonic day 16.5. A het-
erozygous embryo from a Tal2/64 breeding was dissected at E16.5
and sections of the brain were stained for b-galactosidase after
sectioning with a sliding microtome (60-mm sections). The section
in A is a parasagittal section of the whole brain stained with X-gal
and indicating the levels at which the sections shown in B–D wereucleus of the hypothalamus (pvh). Pl, pineal gland.
m
b
540 Bucher et al.FIG. 6. Abnormalities of superior and inferior colliculi in Tal2 homozygous mutant mice. Littermates from a cross between Tal2
heterozygous mutant animals were sacrificed at 15 days after birth and the brains were dissected for analysis. (A) Dorsal views of these brain
preparations of wild-type (1/1), Tal2 heterozygous (1/2), and Tal2 homozygous (2/2) animals. This comparison shows dysgenesis of the
esencephalic tectum in Tal2 2/2 mice. Wild-type and heterozygous animals show a normal tectum, whereas in the null mutant mouse,
oth the superior and the inferior colliculi (SC and IC, respectively) show dysgenesis. The superior is reduced in size and the inferior
o541Abnormal Brain Development in Tal2 Null Micechromosomal translocation (Xia et al., 1991). The specific
association with T cell tumors suggested that the gene
might be expressed, and therefore functional, in hematopoi-
esis as it is thought that chromosomal translocations occur
at open chromatin sites where gene transcription occurs.
Such a function for TAL2 would not preclude more wide-
spread functions, particularly in light of expression of the
gene in mouse brain and testis (Xia et al., 1991; Mori et al.,
1999). Therefore, the function of the mouse Tal2 gene was
investigated by creating null mutations by gene targeting.
We could find no evidence of a hematopoietic defect in Tal2
null mutant mice using the criterion of surface marker
expression compared to control mice. However, we ob-
served that Tal2 function is essential for normal CNS
development and survival.
Tal2 Function Is Required for Normal Midbrain
Development
During embryogenesis, b-galactosidase levels, used as a
reporter for Tal2 promoter activity, are high in the midbrain
(Figs. 2 and 3) reflecting the activity of the Tal2 promoter.
These expression levels taper off during embryonic devel-
FIG. 7. Hydrocephalus occurs in Tal2 null mutant mice after birt
size at P16 and genotypes confirmed postmortem by PCR analysis
and fixed in formalin and coronal 40-mm sections were prepared
exhibits normal lateral ventricles and a narrow opening of the foram
enlargement of the lateral ventricles and flattening and compressio
of the foramen of Monro. F, fornix; FM, foramen of Monro.
colliculus shows an abnormally rounded, protruding morphology.
activity. The superficial gray (SG) is hypoblastic and hardly visible
thickness and in lateral extension. SC, superior colliculus; IC, inferi
(D, E, H, and J) Stained with cresyl violet; (B, C, F, and G) stained
colliculus; OL, optical layer; PG, paraaquiductal gray; SG, superfici
mice or Tal2 null mice are indicated as 1/1, 1/2, or 2/2 respectivelypment and very little b-galactosidase activity can be found
after birth. The homozygous null mutant Tal2 mice are
born and initially appear normal, but die between 13 and 32
days after having shown signs of runting. As a high degree of
Tal2 expression occurs in the midbrain, we focused studies
on the development of that region. We were intrigued by
the discrepancy between time of Tal2 expression and oc-
currence of overt symptoms in the young Tal2 null mutant
mice. Our strategy to elucidate the phenomenon was to
examine and compare the 1/2 and 2/2 mice during
development, potentially enabling us to detect loss of
X-gal-positive cells due to complete lack of wild-type Tal2
protein. The X-gal staining of the compared animals was
identical by microscopic examination and no differences
could be found.
During embryonic development we could not detect any
malformations in Tal2 null mice compared with wild-type
and heterozygous mice. However, considerable develop-
ment of the midbrain takes place after birth, and we were
able to observe subtle differences of the midbrain tectum
morphology as early as day P2 which were sufficiently
prominent to enable us to distinguish Tal2 null mice from
their littermates. At P15, the abnormal morphology of the
mozygous and heterozygous Tal2 mutant mice were identified by
Materials and Methods). Brains were obtained from perfused mice
tained with cresyl violet. Whereas the Tal2 wild-type mouse (A)
f Monro, the Tal22/2 null mouse (B) exhibits prominent bilateral
the fimbria fornix along the roof of the thalamus with obstruction
bnormal layering is most prominent in sections stained for AchE
e Tal2 null mouse. In addition, the optical layer (OL)is reduced in
lliculus; CU, lobulus culmen Transverse sections are shown in B–J.
acetylcholinesterase activity. SC, superior colliculus; IC, inferior
y; IG, inferior gray. Specimens from wild-type, heterozygous Tal2h. Ho
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542 Bucher et al.midbrain tectum in the null mutant mice was apparent,
with the superior and inferior colliculus being distorted.
The superior colliculus and the superficial gray layer play
important roles in the visual pathways. The superficial gray
receives input from nearly all retinal ganglion cells in
topographic representation (Linden and Perry, 1983; Cheng
et al., 1995; Drescher et al., 1995; Zhu and Julien, 1999).
The retinal axons enter through the optical layer and
project to cells in the superficial gray and in turn send axons
into deeper layers where other sensory systems are repre-
sented (Paxinos, 1995).
We have observed relatively few, highly dispersed lacZ-
positive cells in the SC of 1/2 and 2/2 in 16/17 mice. As
the same pattern appears in 1/2 and 2/2 mice, Tal2-
expressing cells probably do not die. It is more likely that
these cells simply get diluted by Tal2-negative cells as
development proceeds. To exclude the possibility that the
few remaining lacZ staining were not due to long-lived
b-gal protein, we assessed the endogenous Tal2 expression
in superior colliculi of wild-type mice at P16 by Northern
analysis and by RT-PCR. While RT-PCR gave a positive
signal, the Northern hybridization showed only a very weak
Tal2 band. These data are consistent with the persistence of
a few expressing cells at postnatal times P15/P17. There are
several possible mechanisms by which postnatal defects
can occur in the absence of widespread Tal2 expression at
later time points. First, a subset of SC cells (normally Tal2
positive) may be needed for differentiation of Tal2-negative
cell in the superficial gray (e.g., requiring signals by cell/cell
contact during development or after birth, which are lack-
ing in the Tal2 null mice). Second, an inherited abnormality
may occur in previously Tal2-positive cells or their precur-
sors and, third, a second gene may be spatially expressed
and encode a protein which compensates for Tal2 functions
up to its transcriptional silencing, only after which Tal2
null phenotype can be manifested.
Premature Death of Tal2 Null Mutant Mice
Expression studies described here using the lacZ
knock-in approach and those using in situ hybridization
(Mori et al., 1999) concur on the sites of Tal2 expression
during embryogenesis. Neither study found evidence of
extensive or substantial Tal2 expression after birth. The
onset of runting and eventual premature death of Tal2 null
mutant mice do not obviously correlate with Tal2 expres-
sion. At death, the null mutant mice show a prominent
hydrocephalus. We found prominent distention of one or
both lateral ventricles in the null mutant mice, in addition
to the occlusion of the foramen of Monro and flattening of
the surrounding fornix area in all animals, suggesting that
an obstruction occurs at this point. At the time preceding
the development of the hydrocephalus and in stages in
which a hydrocephalus is overt in null mutant animals
(P0–P17), we could not find lacZ staining (either in the
heterozygous or in the homozygous mice) in the vicinity of
the foramen of Monro (carefully screened PO, P5, P14,15/P17). However, earlier in embryonic development we
bserved b-galactosidase expression in the ventral dien-
cephalon close to the diencephalic–telencephalic border
and in the mammillary region. In this setting absence of
Tal2 expression in null mutant mice in the rostral dien-
cephalon, extending from the optic recess into the gangli-
onic eminence, in parallel with the developing foramen of
Monro (Fig. 3), may lead to obstruction and thus to hydro-
cephalus. Hydrocephalus, with compression of vital CNS
structures, is likely to be responsible for the death of the
Tal2 null mice.
Promiscuity and Synergy of Transcription Factors
in Development and Tumorigenesis
Genes activated by chromosomal translocations very
often encode transcription factors (Cleary, 1991; Rabbitts,
1991) which function via protein–DNA or protein–protein
interaction (Rabbitts, 1994). In addition, many of the genes
activated by these chromosomal translocation are normally
involved in developmental control but not necessarily in
the tissue type in which they cause tumors. TAL2 is an
xcellent example. It has only been implicated in T cell
umors in man (Baer, 1993), and yet it has no apparent role
n normal hematopoiesis, rather having a vital role in brain
evelopment. The opposing functions of TAL2 in normal
nd malignant development are presumably mediated by its
HLH domain. TAL2 can associate with other HLH pro-
eins (e.g., E47), through this domain, to form DNA-binding
omplexes which can presumably modulate transcription
Xia et al., 1994). This dimerization potential might explain
oth the tropism of TAL2-mediated tumorigenesis and the
pecific role played by TAL2 in normal brain development.
n its normal setting, TAL2 may bind to its appropriate
HLH targets to form transcriptional complexes necessary
or proper brain development. By contrast, the enforced
xpression of TAL2 by tumor-specific chromosomal trans-
locations may disturb the normal network of interacting
HLH proteins in a manner that elicits malignant transfor-
mation of T-lineage cells. Thus T cell expression of TAL2
may sequester HLH proteins from their normal role and/or
it may cause formation of protein complexes which bind
DNA and lead to inappropriate gene expression.
Finally, from our current studies and from previous in
situ hybridization work (Mori et al., 1999), it seems that
some Tal2 expression occurs in regions in the brain which
overlaps with those reported for Tal1 (Sinclair et al., 1999),
including the pretectum, posterior commissure, and tectal
commissural fiber tracts. Tal1 and Tal2 are not thought to
dimerize with each other for their transcriptional functions.
Therefore, it is conceivable that these two bHLH proteins
compete for other protein factors in a developmental-stage-
specific fashion. A relationship between Tal2 and Pax7
protein is also possible in view of the documented Pax7
expression in the superior colliculus of postnatal mice and
Pax7 null mutant mice have a very similar phenotype
(Mansouri et al., 1996). Furthermore, there may be partial
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543Abnormal Brain Development in Tal2 Null Miceredundancy in function between Tal1 and Tal2 (as has been
described for Pax3/Pax7, Pax2/Pax5, or Jnk1/Jnk2 where
one can partially replace the function of the homologous
partner (Urbanek et al., 1997; Mansouri and Gruss, 1998;
Kuan et al., 1999)). This could explain why the Tal2-
deficient mice show no severe prenatal abnormalities in
developing fiber tracts. Such putative cross-functions in
CNS cannot be assessed as yet since Tal1 null mutant mice
have early embryonic lethality due to failure of hematopoi-
esis (Robb et al., 1995, 1996; Shivdasani et al., 1995; Porcher
t al., 1996).
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